Dr. Shim has a diverse range of expertise in MR spectroscopy, PET chemistry, cancer biology, and pharmacology. Her research focuses on chemokine CXCR12 and its receptor CXCR4 in cancer invasion/metastasis, and she has led an interdisciplinary research team to discover a series of diverse, potent anti-CXCR4 molecules. In addition, her research team has developed an advanced MRSI technique combined with a multi-modality imaging platform to assess how glioblastomas are responding to therapies by quantitatively measuring metabolic processes.
Professor, Crocker Family Chair in Cancer Innovation, Scientific Director of Medical Physics
Winship Cancer Institute C5008